AUDUBON, Pa., Sept. 16, 2025 /PRNewswire/ — AIROS® Medical, Inc. , a medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous complications, today announced the launch of expanded sizing for its truncal garments. These…
Peripheral/Endo
PatenSee Receives FDA Breakthrough Device Designation for Non-Contact Vascular Access Management for Patients Undergoing Hemodialysis
Designation supports accelerated development of AI-driven platform to improve outcomes and reduce clinical burden. DETROIT and OR YEHUDA, Israel, Sept. 16, 2025 /PRNewswire/ — PatenSee, a clinical-stage medical device company, announced that the U.S. Food and Drug Administration (FDA)…
Johnson & Johnson Announces Launch of its Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions
SANTA CLARA, Calif. – September 15, 2025 – Today, Johnson & Johnson announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium in extremely narrowed vessels to expand treatments in patients suffering from peripheral artery disease (PAD). The first-of-its-kind Forward IVL […]
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
– Results were published in the Journal of Vascular Surgery –
Late Breaking Clinical Trial from AVS IVL Pivotal Study to be Presented at VIVA
POWER PAD II IDE trial evaluates safety and efficacy of the Pulse IVL™ system in patients with severely calcified peripheral arterial disease BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it will present 30-day results of its […]
Vascular Innovation on Display: The VIVA Foundation Set to Unveil Latest Trial Data at The VEINS and VIVA 2025
PALM SPRINGS, Calif., Sept. 10, 2025 /PRNewswire/ — The VIVA Foundation will once again showcase the most influential new data in vascular medicine on a global stage. From Saturday, November 1, through Tuesday, November 4, results from 23 clinical trials will be presented during The…
Shape Memory Medical Completes Enrollment in the EMBO-Post Market Surveillance Registry
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., the innovator of shape memory polymer for endovascular applications, announced the completion of patient enrollment in the EMBO Post Market Surveillance (EMBO-PMS) Registry, the Company’s prospective, multicenter registry of the IMPEDE and IMPEDE-FX Embolization Plugs, and IMPEDE-FX RapidFill Device when used for peripheral […]
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System.
Silent Vascular Threat: Nearly 70% of Americans Unaware of PAD – The Leading Cause of Preventable Amputations
During PAD Awareness Month, the Society for Vascular Surgery Urges Americans to Learn How to Safeguard Their Vascular Health ROSEMONT, Ill., Sept. 8, 2025 /PRNewswire/ — Despite vascular disease dominating headlines in recent months—from prominent public figures with visible symptoms and…
ASAHI INTECC Launches Veloute™ and Tellus™ Embolization Microcatheters in the U.S.
Next-generation deliverability and control for peripheral embolization — available September 8, 2025 IRVINE, Calif., Sept. 8, 2025 /PRNewswire/ — ASAHI INTECC today announced the U.S. commercial launch of Veloute™ and Tellus™. These medical devices are indicated for angiography and…



